In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements. < Back Q1 FDA warning letter roundup with Asa Waldstein Asa Waldstein Guest Article In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements. Read More Previous Next

< Back Panel Discussion Friday Mar 26, 2021 Regulatory Reality on the Horizon NoCo Hemp Expo, Denver, CO I am honored to share the stage with industry icons Robert Hoban and Tim Gordon . They are some of my industry favorites, and I am so excited about our regulatory panel! The industrial hemp business community is encouraged to stay vigilant, involved and up to date as a number of federal and state bills, USDA, FDA and DEA proposed regulations, and other policy activities impact the hemp market – and your business – on state, national and international levels. Learn more Previous Next

A multi-year case involving dietary supplement startup PPO Lab, the Federal Trade Commission (FTC) and COVID-19-related health claims has come to a close, culminating in a truce that removes fines and lightens administrative burdens on the defendants. < Back FTC settles with supplement startup over COVID claims Asia Sherman Interview A multi-year case involving dietary supplement startup PPO Lab, the Federal Trade Commission (FTC) and COVID-19-related health claims has come to a close, culminating in a truce that removes fines and lightens administrative burdens on the defendants. Read More Previous Next

Asa Waldstein, principal at Supplement Advisory Group, advises companies on how to navigate murky waters in today's marketplace. < Back Limiting Marketing Risk for Hemp and CBD Products Sheldon Baker Interview Asa Waldstein, principal at Supplement Advisory Group, advises companies on how to navigate murky waters in today's marketplace. Read More Previous Next

< Back In-Person, Panel Discussion Thursday May 11, 2023 Considerations in entering the US market: Pitfalls, best practices, regulatory and innovation needs Vitafoods Insights Theatre Geneva, Switzerland The US remains one of the largest and most important markets for food and dietary supplements. Although it is also one of the most competitive and innovation-friendly markets globally, it is not unregulated despite its very open appearance. In this panel discussion, attendees will gain invaluable information to better understand the US market - its consumers, innovations, and regulatory requirements to succeed. The panel will also review the legal framework and how it is regulated; what are the major distribution channels, how to engage them, and how they have recently changed; and what are some important trends across global brands. Panelists include: Asa Waldstein, Principal Supplement Advisory Group Kenn Israel, Co-Founding Partner BeyondBrands Dr. David Foreman, President The Herbal Pharmacist More Information Previous Next

< Back In-Person, Solo presentation Wednesday Jun 5, 2024 The Regulatory Process The Mushroom Summit Monterey, CA Evaluate the Regulatory Landscape and Identify What You NEED to Know to Bring Your Functional Mushroom Product to Retail Shelves Identify the current regulations pertaining to the selling of functional mushrooms Discuss what the regulatory process looks like and the timeline Evaluate potential upcoming changes to regulations and their impact See Asa's LinkedIn post about this event here . Learn more Previous Next

< Back Presentation, In-Person Thursday Oct 26, 2023 Microbiome Products: Enforcement & Marketing Compliance Supplyside West Las Vegas A universe unfolding: Uncovering the mysteries of the microbiome and its connection to health Despite a deluge of new information—and a steady stream of microbiome-related studies expanding the available data on human microbiome composition and function—ingredient researchers are only beginning to understand the individual microbial species and their biological roles. Luckily, artificial intelligence (AI) and machine learning are proving to be game changers in our understanding of these expanding datasets. Technology could bring transformational change through the development of predictive models for personalized therapeutic interventions or disease interception. But before that lofty goal is reached, biotics providers are discovering the impact that bacteria-based ingredients can have on a wide range of health systems beyond gut health, including the gut-brain axis, a connection to healthy skin, and the influence of dysbiosis on host immunity and disease. The session covered: Innovation in product development across a range of consumer-facing solutions that include prebiotics, probiotics, synbiotics and postbiotics. The segment expansion of probiotics into sports nutrition, weight management, inflammation targeting and cosmetics, as well as bone health, women’s health, kidney and respiratory function, cognitive performance, and stress and sleep. The accumulation of in vivo and clinical data indicating that probiotics could represent important allies in the fight against obesity and associated metabolic health concerns. Learn More Previous Next

The developing state and federal regulatory situation for ingestible CBD and hemp have made marketing these products a bit tricky. < Back The Complexities of Marketing Hemp Products Asa Waldstein Guest Article The developing state and federal regulatory situation for ingestible CBD and hemp have made marketing these products a bit tricky. Read More Previous Next

In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements. < Back Q2 2025 warning letter roundup with Asa Waldstein Asa Waldstein Guest Article In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements. Each quarter, I provide updates on notable FDA warning letters and enforcement trends. Understanding enforcement trends is essential for being a savvy marketer, regulatory affairs professional or dietary supplement executive. Have you wondered why FDA issues warning letters to certain companies and not others? FDA likes to make examples of companies not following the rules in areas they want to focus on, many of which I review here. Staying ahead of trouble is one of the critical and fun reasons to follow enforcement trends. This warning letter roundup focuses on social media warning letters, unallowable ingredients and a CBD update. I hope you enjoy it! Read More Previous Next